Today’s Solutions: March 19, 2026

Goldman Sachs says the technology “has the potential to redefine transactions” and can change “everything.” JPMorgan last month announced it was launching a trial project with the blockchain startup led by its former executive, Blythe Masters. Her company, Digital Asset Holdings, has secured funding from Goldman, Citi, ICAP, and a boatload of other financial firms. If you’re wondering what a blockchain actually is, or how its works, you’re not alone. Autonomous Research, which calls the technology a “game changer,” has released a report to answer all of your blockchain questions. The important thing to understand is that it has nothing to do with bitcoin — at least for Wall Street’s purposes. Blockchain is the technology behind bitcoin, but it has many other uses too. Wall Street wants to use blockchains to simplify the way it processes transactions.  That may not sound very exciting, but if it works, it could eliminate back office jobs and costs. So it’s worth paying attention to — especially if you’re one of the thousands of people who work in bank back offices. Here’s how it works.

Print this article
More of Today's Solutions

Overthinking is a learned habit, and therapists say you can unlearn it

BY THE OPTIMIST DAILY EDITORIAL TEAM "Just stop overthinking" is advice that tells you nothing useful about how to actually follow it. The mind ...

Read More

A single dose of psilocybin gave smokers six times better odds of quitting th...

BY THE OPTIMIST DAILY EDITORIAL TEAM A new clinical trial from Johns Hopkins University produced results that surprised even the researchers behind it. Participants who ...

Read More

Rusty social skills? 5 ways to reconnect with socialization

Now that there are more opportunities to go out and socialize, you may be experiencing some mixed emotions regarding social events. You may have ...

Read More

AI-powered blood test shows promise in early breast cancer detection

BY THE OPTIMIST DAILY EDITORIAL TEAM Early detection of breast cancer dramatically increases survival rates, but identifying the disease in its earliest stages remains ...

Read More